5.51
price up icon0.92%   0.05
after-market Dopo l'orario di chiusura: 5.54 0.03 +0.54%
loading

Immuneering Corp Azioni (IMRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
16.56%
15.48
18.56 15.27 14.91 15.33
Operating Income/Loss
16.56%
-15.48
-18.56 -15.27 -14.91 -15.33
Income/Loss From Continuing Operations Before Tax
16.65%
-15.05
-18.05 -14.60 -14.08 -14.31
Income/Loss From Continuing Operations After Tax
16.65%
-15.05
-18.05 -14.60 -14.08 -14.31
Net Income/Loss
16.65%
-15.05
-18.05 -14.60 -14.08 -14.31
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9,800%
35.53
0.3589 29.84 29.65 29.37
Diluted Average Shares
9,800%
35.53
0.3589 29.84 29.65 29.37
Basic Earnings Per Share
28.81%
-0.42
-0.59 -0.49 -0.47 -0.49
Diluted Earnings Per Share
28.81%
-0.42
-0.59 -0.49 -0.47 -0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):